2012
DOI: 10.4236/ojra.2012.24017
|View full text |Cite
|
Sign up to set email alerts
|

The Frequency of Fibromyalgia Syndrome and the Quality of Life in Patients with Peritoneal Dialysis

Abstract: Objective: The aim of this study was to determine the frequency of fibromyalgia (FM) in patients on Peritoneal Dialysis (PD) and to investigate its impact on the quality of life of that population. Methods: A hundred and twenty four patients with end stage renal disease who had undergone PD, and a control group of 54 age and sex-matched healthy volunteers were included to the study. Demographic characteristics including age, sex, disease and dialysis duration were recorded. Fibromyalgia Impact Questionnaire (F… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(15 citation statements)
references
References 21 publications
1
13
1
Order By: Relevance
“…23 Of the 14 studies in our analysis, 2 reported fibromyalgia-FGID comorbidity rates of less than 20%. Okumus et al investigated IBS in patients with end-stage renal disease (ESRD), 52 and found that 16.7% of patients with both ESRD and fibromyalgia had IBS, compared with 7.1% of those with ESRD but without fibromyalgia. Given the known alterations to the gut microbiome in patients with renal disease, 55 the low comorbidity suggests the small patient group (n = 12 with ESRD plus fibromyalgia versus those with ESRD only n = 112 ) may underlie the non-significant difference reported.…”
Section: Discussionmentioning
confidence: 99%
“…23 Of the 14 studies in our analysis, 2 reported fibromyalgia-FGID comorbidity rates of less than 20%. Okumus et al investigated IBS in patients with end-stage renal disease (ESRD), 52 and found that 16.7% of patients with both ESRD and fibromyalgia had IBS, compared with 7.1% of those with ESRD but without fibromyalgia. Given the known alterations to the gut microbiome in patients with renal disease, 55 the low comorbidity suggests the small patient group (n = 12 with ESRD plus fibromyalgia versus those with ESRD only n = 112 ) may underlie the non-significant difference reported.…”
Section: Discussionmentioning
confidence: 99%
“…While rates of major depressive disorder (148/1374, 10.77%) were close to the frequency of depressive symptoms among predialysis patients (13%) attending a single renal center [ 32 ], they were lower than the reported prevalence of depressive symptoms among patients with CKD who are not on dialysis (21%-42%) [ 33 ]. The proportion of patients with fibromyalgia (199/1374, 14.48%) was higher than that previously reported in patients with CKD receiving hemodialysis (3.9%-12.2%) [ 34 - 37 ] or peritoneal dialysis (9.7%-18%) [ 38 , 39 ]. This may be due to the nature of the PLM database, where large communities for chronic conditions including fibromyalgia exist [ 17 ].…”
Section: Discussionmentioning
confidence: 59%
“…Two of the fourteen studies in our analysis reported fibromyalgia-FGID comorbidity rates of less than 20%. Okumus (42) investigated IBS in patients with end-stage renal disease (ESRD) and found that 16.7% of patients with both ESRD and fibromyalgia had IBS, compared to 7.1% of those without fibromyalgia. Given the known alterations to the gut microbiome in patients with renal disease (45), the low comorbidity suggests the small patient group (n = 12 with ESRD plus fibromyalgia versus those with ESRD-only n = 112 ) may underlie the non-significant difference (p-value not given).…”
Section: Discussionmentioning
confidence: 99%
“…One study set out to examine the prevalence of the range of FGIDs in fibromyalgia (41), five (20,32,34,35,39) focused on IBS. In four studies (31,33,36,40) IBS was recorded as part of a bigger research question and in the remaining four studies (30,37,38,42) IBS data was reported as a secondary not primary outcome measure. Four studies (32,34,37,38) included additional cohorts of patients with IBS; these subjects are excluded from control data presented in Table 2.…”
Section: Data Extractionmentioning
confidence: 99%
See 1 more Smart Citation